Last reviewed · How we verify
6X level of MSCs-Exo — Competitive Intelligence Brief
phase 1
Biologic
Live · refreshed every 30 min
Target snapshot
6X level of MSCs-Exo (6X level of MSCs-Exo) — Ruijin Hospital.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| 6X level of MSCs-Exo TARGET | 6X level of MSCs-Exo | Ruijin Hospital | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- 6X level of MSCs-Exo CI watch — RSS
- 6X level of MSCs-Exo CI watch — Atom
- 6X level of MSCs-Exo CI watch — JSON
- 6X level of MSCs-Exo alone — RSS
Cite this brief
Drug Landscape (2026). 6X level of MSCs-Exo — Competitive Intelligence Brief. https://druglandscape.com/ci/6x-level-of-mscs-exo. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab